Finlands Akademi
Finansieringsbeslut
 
Sökande / Kontakt person Yli-Kauhaluoma, Jari
Organisation Helsingfors universitet
Projektets titel Sustainable Drug Discovery and Development with End-of-Life Yield
Beslutnr 320210
Beslutsdatum 26.11.2018
Finansierings period 01.11.2018 - 31.12.2021
Finansiering 1 501 092
WebFOCUS Report
Beskrivning av projektet
The ecological risks related to pharmaceutical emissions are an increasing concern both locally and globally. Hormonal and antibiotic residues are particularly harmful even at very low concentrations. Current societal transformations incl. urbanization, population growth and ageing, contribute to the accumulation of pharmaceuticals in the environment at an accelerated pace. The SUDDEN project tackles the environmental hazards and sustainability challenges related to drug manufacturing, consumption, and end-of-life. The project aims to enhance the benign-by-design drug discovery, bridge the gaps in the legal framework of global production chains of pharmaceuticals, redesign modern wastewater purification and reuse of the sewage sludge, and introduce circular economy models to pharmaceutical packaging materials with a view to developing a Life Cycle Impact Assessment model to drug products and supporting the economic growth of sustainable pharmaceutical industry and services in Finland.